SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Maul Coin

Maul Coin is currently experiencing significant community-driven momentum as followers push for increased visibility and a proper trading chart on financial platforms. The community is actively discussing the potential for parabolic gains and long-term project growth, while debating strategies for maintaining support levels and attracting new investors.

Ethereum is a global, open-source platform for decentralized applications. In other words, it is a decentralized blockchain platform that enables developers to build and deploy smart contracts and applications without central authority control. Unlike Bitcoin, which primarily functions as digital currency, Ethereum operates as a programmable global computer where developers can create any type of decentralized service.   The platform hosts over $14 billion in DeFi applications with hundreds of thousands of active users across financial protocols, NFT marketplaces, and gaming platforms. Its transition to Proof of Stake in September 2022 reduced energy consumption by over 99%, addressing environmental concerns while strengthening network security.  The network operates through thousands of independent validator nodes that process transactions and execute smart contracts on the Ethereum Virtual Machine. Smart contracts are self-executing programs written in Solidity that automatically carry out agreements when conditions are met, eliminating intermediaries like banks or brokers.   Validators stake ETH as collateral to propose and validate blocks, earning rewards for honest participation while facing penalties for malicious behavior. The EIP-1559 upgrade introduced a dynamic base fee mechanism that burns ETH with each transaction, creating deflationary pressure during high network activity when more ETH is burned than issued to validators.  Vitalik Buterin proposed Ethereum in 2013, but seven co-founders helped build it, including Gavin Wood who created Solidity and the EVM technical specification, and Joseph Lubin who founded ConsenSys. The project launched in July 2015 after raising over $18 million through crowdfunding, quickly becoming the largest blockchain developer community. Major milestones include the 2020 Beacon Chain launch, the 2021 London hard fork implementing fee burning, and the 2022 Merge to Proof of Stake.   Ether (ETH) serves multiple functions: paying transaction fees (gas), staking to secure the network and earn 3-5% annual yields, serving as collateral in DeFi protocols, and purchasing NFTs and digital assets. The asset is increasingly adopted by traditional institutions, with publicly traded companies adding ETH to corporate treasuries to generate staking yields while maintaining blockchain exposure, and in 2024, the SEC approved spot Ethereum ETFs, allowing traditional investors to gain exposure through conventional brokerage accounts.  Ethereum's roadmap focuses on dramatically increasing transaction capacity to over 100,000 per second, reducing confirmation times, and enhancing decentralization while maintaining security against future threats like quantum computing.

Ethereum

Ethereum is trending as investors debate the impact of broader geopolitical tensions and institutional accumulation on its price action, with the community actively discussing potential volatility and the impact of the upcoming Iran-related deadline. Traders are heavily focused on critical support and resistance levels, while others highlight the ongoing influence of major institutional buying trends and long-term network value.

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

Ripple is currently trending as the community debates the impact of institutional integration and regulatory developments, with traders expressing frustration over stagnant price action versus excitement for potential long-term utility. Sentiment remains sharply divided, featuring intense discussions on whether upcoming legal clarity or banking adoption will catalyze a breakout or confirm long-term bear-market frustrations.

Avalo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the treatment of immune dysregulation by developing therapies that target the LIGHT-signaling network. It also focuses on reducing LIGHT levels which can moderate immune dysregulation in many acute and chronic inflammatory disorders. The company was founded by Blake M. Paterson, Isaac Blech, Barbara S. Slusher, and Solomon H. Snyder on January 31, 2011 and is headquartered in Wayne, PA.

Avalo Therapeutics Inc

Avalo Therapeutics is attracting significant attention as investors monitor its lead pipeline candidate, AVTX-009, with the community actively tracking upcoming Phase 2 trial results and potential institutional interest. Market participants are expressing high interest in the stock's volatility and volume spikes, closely debating the balance between promising clinical data catalysts and ongoing funding and dilution risks inherent to the biotechnology sector.

Canton Coin (CC), the network’s native utility token, was designed to reward real network usage over speculation. It aligns the success of the network with the participants who make it work, fairly rewarding app builders and app users, as well as those operating decentralized infrastructure. The result is a fundamentally different model where rewards flow to those creating value through real activity, not only miners or early investors.

Canton

Canton is gaining significant traction as investors highlight growing institutional adoption, including high-profile partnerships with major financial firms and infrastructure providers. The community is actively discussing the network's role in tokenized asset settlement, the recent validator lock-up requirements, and its expanding presence on major exchanges.

The Mullen Army Token originated from a dedicated community of retail investors who faced challenges in the traditional stock market. We united to create a cryptocurrency that embodies our principles and aspirations for a fair financial system.     We provide a platform for retail investors to engage in a transparent and fair financial market. Our efforts include grassroots marketing, community engagement, and educational content to empower our investors.

MullenArmy

The MullenArmy cryptocurrency project is facing intense scrutiny from the community, with many investors labeling it a derivative scam that mirrors the controversial history of the associated automotive stock. While proponents continue to push for a resurgence and community-led momentum, vocal critics are actively warning others to avoid the token and steer clear of its alleged pump-and-dump mechanics.

Cloudflare, Inc. engages in the provision of cloud-based services to secure websites. It offers various products for performance and reliability, video streaming and delivery, advanced security, insights, Cloudflare for developers, domain registration, and Cloudflare marketplace. It operates through the United States and Rest of the World geographical segments. The company was founded by Matthew Prince, Michelle Zatlyn, and Lee Holloway in July 2009 and is headquartered in San Francisco, CA.

Cloudflare Inc - Ordinary Shares - Class A

Cloudflare Inc

Cloudflare is trending as investors weigh its potential as a critical infrastructure backbone for the rising 'agentic' AI economy, fueled by viral adoption of tools like Moltbot. While bullish community sentiment highlights the stock's role in the internet's structural re-platforming, the price action remains volatile as the market debates whether the stock's premium valuation is justified by AI-driven growth or vulnerable to broader software sector de-rating.

Airbnb, Inc. engages in the management and operation of an online marketplace. Its marketplace model connects hosts and guests online or through mobile devices to book spaces. The company was founded by Brian Chesky, Nathan Blecharczyk and Joseph Gebbia in 2007 and is headquartered in San Francisco, CA.

Airbnb Inc - Ordinary Shares - Class A

Airbnb Inc

Airbnb shares are generating buzz as investors weigh the stock's long-term compounding potential against ongoing concerns about travel demand, regulatory pressures, and competition in the short-term rental market. Community sentiment remains polarized, with many traders debating whether current price levels represent an undervalued entry point or a sign of continued stagnation.

Sound Group, Inc. is a global, AI-powered audio company on a mission to help people connect better and live happier. Leveraging its voice AI technologies and deep expertise in audio interaction, Sound Group is building a diverse ecosystem of intelligent audio products that cater to a global user base. By integrating technology, innovative products, and real-world data within a user-centric ecosystem, Sound Group generates a powerful growth flywheel that is driving continuous innovation and accelerating global expansion. The company was founded by Jinnan Lai and Ning Ding in 2010 and is headquartered in Singapore.

Sound Group Inc - ADR

Sound Group Inc

Sound Group Inc. is trending as investors debate the impact of its recent special dividend and share buyback initiatives against a backdrop of volatility common to its sector. While some community members highlight the company's strong revenue growth and AI-driven product ecosystem as justification for a potential re-rating, others remain skeptical, citing regulatory risks, unaudited financial concerns, and potential market manipulation.

BlackRock, Inc. engages in the provision of investment, advisory, and risk management solutions. Its products include single-asset and multi-asset portfolios. The company was founded by Laurence Douglas Fink and Robert Steven Kapito in 1988 and is headquartered in New York, NY.

Blackrock Inc.

BlackRock is facing heightened market scrutiny as it joins a growing list of major firms limiting redemptions from private credit funds, fueling investor concerns over liquidity and underlying loan quality. Despite this pressure, the firm remains a focal point for institutional capital as it aggressively expands its digital asset and tokenization initiatives.

statis crypto Watchlist

Bitcoin

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Defense, Biotech, and Aerospace Stories Dominate

Markets are opening Thursday with a mix of defense innovation, biotech progress, aerospace supply chain momentum, and turnaround earnings, highlighting how technology and strategic manufacturing continue to drive investor attention across several sectors. From next-generation biomaterials to counter-drone systems and aerospace electronics, the latest corporate developments suggest continued capital flow toward industries tied to national security, healthcare innovation, and advanced manufacturing. $KBLB, $IBO, $GXAI, $MOBX, $BTAI, $ALTO

<ul class="summary-bullets"><li>Under the revised agreement, the combined public company will issue around 169.6 million ordinary shares.</li><li>The combined public company will also issue 128,000 shares to DSS, its parent company.</li><li>This follows a June 2025 agreement to combine Dr Ashleys’ manufacturing with Impact BioMedical’s portfolio of more than 90 medical patents.</li></ul>Shares of Impact BioMedical (IBO) soared over 65% in pre-market trading on Thursday, after the company announced amendments to agreements tied to its planned merger with Dr Ashleys.If the pre-market level holds after the opening bell, <a href="https://stocktwits.com/symbol/IBO">IBO stock</a> would hit its highest since Sept. 12, 2025.<h2 class="st-heading-2">PubCo To Issue 169.6 Million Shares</h2>Under the revised agreement, the combined public company, referred to as PubCo, will issue 169,560,000 ordinary shares, which represent about 94.2% of PubCo’s outstanding shares at the closing of the business combination. These shares are called the Company Share Consideration.PubCo will issue 22,000 shares to Impact’s CEO, Frank D. Heuszel, and up to 128,000 shares to DSS in two batches. DSS is the parent company of Impact BioMedical. These shares will be&nbsp;deducted from the PubCo’s Company Share Consideration.Additionally, the deadline to complete the merger was extended from March 31, 2026, to July 1, 2026, while shareholders who support the transaction currently control about 88.9% of Impact BioMedical’s shares.<h2 class="st-heading-2">Merger To Open Up Manufacturing Access For Impact</h2>In June 2025, Impact BioMedical and Dr Ashleys signed a definitive merger agreement with Dr Ashleys. The transaction will create a new holding company that will own both Dr Ashleys and Impact BioMedical as subsidiaries. The combined company will be led by Dr Ashleys’ executive team and a newly appointed board.The merger aims to combine Dr Ashleys’ manufacturing and global market access with Impact BioMedical’s portfolio of more than 90 patents covering treatments for cancer, infectious diseases, respiratory illnesses, and orphan drugs.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>The stock garnered significant retail buzz, with Stocktwits data indicating a 14,200% increase in message volumes over the past 24 hours, while retail sentiment on the platform turned ‘extremely bullish’ from ‘bullish’ a day back.<img src="https://news.stocktwits-cdn.com/ibo_jpg_729ebe600c.webp" alt="ibo.jpg">One user sees a rally if the stock breaks over $0.8. It is currently at $0.69.<stembedurl>https://stocktwits.com/TroubleMaker/message/646636004</stembedurl>Another user sees the stock climbing to the $2.45 - $3 range.<stembedurl>https://stocktwits.com/Flybeast/message/646657749</stembedurl>Year-to-date, the stock has gained around 36%.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/why-did-btai-stock-surge-in-pre-market-today/cZdQs29RI3E">Why Did BTAI Stock Surge 20% In Pre-Market Today?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Why Did IBO Stock Surge 65% In Pre-Market Today?

The company announced amendments to agreements related to its planned merger with Dr. Ashley's, including extending the deadline to complete the merger to July 1, 2026.

IBO Stock Spikes Pre-Market: Retail Traders Pile Into Biotech Penny Stock After Merger Update

Equity

Impact BioMedical, Inc. is a holding company, which engages in the discovery and development of products and treatment options in specialty biopharmaceuticals and consumer healthcare. The firm focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological and immune related diseases. It is also involved in developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. The company was founded on October 16, 2018 and is headquartered in Houston, TX.

Impact BioMedical Inc.

Opendoor ($OPEN)

Strategy ($MSTR)

American Eagle ($AEO)

Ondas Inc. ($ONDS)

The stock that proved the power of the crowd. Fueled by community energy and social momentum, this winner captivated retail investors regardless of what the "experts" or traditional fundamentals had to say.

IBO
Impact BioMedical Inc.

Feed

News

Sentiment

Fundamentals

Info

Latest IBO News

IBOImpact BioMedical Inc.